Applications of molecular microbiology to vaccinology

Lancet

Volumn 350, Issue 9086, 1997, Pages 1240-1244

  Moxon, E Richard ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; VACCINE;

ANIMAL; GENOTYPE; HUMAN; MOLECULAR BIOLOGY; REVIEW;

ANIMALS; GENOTYPE; HUMANS; MOLECULAR BIOLOGY; NUCLEIC ACIDS; VACCINES;

EID: 0031586474     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)03259-5     Document Type: Review

References (24)

1. Falkow S. Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 1988; 10: S274-276.
2. Jilg W, Schmidt M, Deinhardt F. Four year experiences with a recombinant hepatitis B vaccine. Infection 1989; 17: 70-76.
3. Murphy BR, Webster RG. Influenza viruses. In: Fields BN, ed. Virology. New York: Raven Press, 1985. 1179-239.
4. Pizza MG, Covacci A, Bartoloni A, et al. Mutants of pertussis toxins suitable for vaccine development. Science 1989; 246: 497-500.
5. Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Eng J Med 1983; 308: 681-85.
6. Tarr PI, Fouser LS, Stapleton AE, et al. Hemolytic-uremic syndrome in a six year old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2. N Engl J Med 1996; 335: 635-38.
7. Deitsch KW, Moxon ER, Wellems TE. Shared themes of antigenic variation and virulence in bacterial, protozoal and fungal infections. Microbiol Molec Biol Rev 1997; 61: 281-93.
8. Kendall AP. Epidemiological implications of changes in the influenza virus genome. Am J Med 1987; 82: S4-14
9. Nowak MA, Bangham CR. Population dynamics of immune responses to persistent viruses. Science 1996; 272: 74-79.
10. Baruch DI, Pasloske BL, Singh B, et al. Cloning the P falciparum gene encoding PfEMP1, a malaria variant antigen and adhesion receptor on the surface of parasitised human erythrocytes. Cell 1995; 82: 77-87.
11. Borst P, Rudenko G. Antigenic variation in African triponosomes. Science 1994; 264: 1872-873.
12. Heckels JE. Structure and function of pili of pathogenic neisseria species. Clin Microbiol Rev 1989; 2: S66-73.
13. Kennedy MJ, Rogers AL, Hanselman LR, et al. Variation in adhesion and cell surface hydrophobicity in Candida albicans white and opaque phenotypes. Mycopathologia 1988; 102: 149-56.
14. Moxon ER, Thaler DS. The tinkerer's evolving toolbox. Nature 1997; 387: 659-62.
15. Anderson RM, May RM. Coevolution of hosts and parasites. Parasitology 1982; 85: 411-26.
16. Lipsitch M, Moxon ER. Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol 1997; 5: 31-37.
17. Moxon ER. Whole genome sequencing of pathogens: a new era in microbiology. Trends Microbiol 1995; 3: 335-37.
18. Hood DW, Deadman ME, Allen T, et al. Use of the complete genome sequence information of Haemophilus influenzae strain Rd to investigate lipopolysaccharide biosynthesis. Molec Microbiol 1996; 22: 951-65.
19. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-68.
20. Ulmer J, Donnelly JJ, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745-49.
21. Hoffman SL, Doolan DL, Sedagah M, et al. Nucleic acid malaria vaccines. Current status and potential. Ann N YAcad Sci 1995; 772: 88-94.
22. Wang B, Ugen KE, Srikantan V, et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci 1993; 90: 4156-60.
23. Masoud H, Moxon ER, Martin A, Krajcarski D and Richards JC. Structure of the variable and conserved lipopolysaccharide oligosaccharide epitopes expressed by Haemophilus influenzae serotype b strain Eagan. Biochemistry 1997; 36: 2091-103.
24. Fleischmann RD, Adams MD, White O, et al. The genome of Haemophilus influenzae Rd. Science 1995; 269: 496-512.